A Study of CBP-1008 in Patients With Advanced Solid Tumor

NCT04740398 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

143

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: CBP-1008

Sponsor

Coherent Biopharma (Suzhou) Co., Ltd.